Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Contact Us
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Sports
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Advanced Manufacturing and Industrials
    • Art and Cultural Property
    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Entertainment & Sports
    • Financial Institutions
    • Healthcare
    • Higher Education
    • Infrastructure
    • Nonprofit Organizations
    • Real Estate
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Videos
    4. Healthcare technology contracts: the intersection of privacy and IP

      Videos

    Healthcare technology contracts: the intersection of privacy and IP

    Nov 19, 2026

    LinkedInX (Twitter)EmailCopy URL

    By Valerie Montague and Jason Kunze

    Healthcare technology contracts: the intersection of privacy and IP

    From boilerplate to breakthrough

    Privacy, IP, and AI terms in healthcare technology contracts.

    Healthcare organizations are moving quickly to adopt AI-enabled tools, including scheduling agents, website chatbots, and ambient scribes. As they do, the contracts behind these tools are getting longer, more complicated, and more contested. Customers now routinely attach their own terms on data privacy, intellectual property, and AI use, which can override a vendor’s standard agreement. Vendors, in turn, have to work out whether they can comply with myriad contractual restrictions while simultaneously protecting their own IP and negotiating the provisions that allow their tool to provide the desired services. 

    In the accompanying video, Nixon Peabody partner Valerie Montague and counsel Jason Kunze are joined by Shawna Doran, Vice President, Associate General Counsel and Chief Privacy and Security Counsel at Veradigm. Together, they look at how HIPAA and other privacy regulations, intellectual property, confidentiality, and AI-specific contract terms are coming together in healthcare technology contracts, and what that means for providers, health plans, life sciences companies, and the vendors that serve them.

    Privacy and data protection 

    • Map the rules before you negotiate. Besides HIPAA, organizations may be subject to 42 CFR Part 2, state health privacy laws protecting specific types of data (such as mental health, HIV/AIDS, genetic, biometric, and reproductive health information), state comprehensive privacy laws, and new state AI and health AI laws. Board policies, offshoring restrictions in other contracts, and public privacy commitments may also limit how data can be used or shared with a vendor. It’s also important to confirm what data elements are actually involved in a proposed arrangement. For example, a HIPAA-regulated organization may be buying a tool that doesn’t use PHI, and whether data counts as de-identified depends on the HIPAA and state law standards that apply.
    • Clarify the vendor’s role and data access. Organizations need to establish whether a vendor is a business associate or a subcontractor business associate, whether it needs the full record or only a limited subset, consistent with the HIPAA minimum necessary requirement, and whether existing EMR and other vendor agreements permit integration, to the extent applicable. For example, an AI scheduling agent that accesses the EMR may not need access to the full medical record. Subcontractor flow-downs add another layer, particularly when a vendor’s subcontracts are already in place and may not be able to be easily modified. These questions, along with the vendor’s security controls, are best addressed through diligence and governance before contracting begins, especially with newer companies that may have limited experience handling health information.
    • Ambient scribes and AI note takers raise distinct issues. These include patient consent in two-party consent states, whether recordings and transcripts can be obtained in litigation, how long they’re kept, and whether they form part of the medical record. Recent lawsuits over AI note-taking tools have included biometric privacy claims and whether such a tool acts for a participant in the conversation or counts as a third party to it. How contracts allocate responsibility for consent and note review is an important issue for both providers and vendors.
    • Patient-facing chatbots require careful design. Some states have adopted or are considering laws on AI and the practice of medicine. Users also often volunteer health information in chatbot conversations. Organizations deploying these tools need to consider how a chatbot handles that information and when it should direct users to clinical care.

    Intellectual property and data rights

    IP ownership and license scope remain core terms. For vendors, customer terms that alter IP ownership or restrict the right to modify the software or create derivative works are often among the most important points to negotiate. License scope matters on the inbound side, too. Third-party data licensed for limited use may prohibit AI training or use, and the data provider may seek additional fees if AI use extends beyond the original license. 

    Data reuse rights carry both value and risk. Whether a vendor may use customer data, including de-identified data and retained prompts, to train or improve AI models is often a central negotiating point and can affect deal economics. Linking de-identified datasets doesn’t necessarily produce a de-identified result, and AI can increase the risk of re-identification. That makes downstream contract protections especially important for organizations licensing health data.

    AI-specific contract terms

    • AI riders may take precedence over the main agreement. Customers often attach AI riders or addenda that purport to control over the vendor’s standard terms. These provisions typically shift more risk to the vendor, for example by adding warranties regarding AI usage, removing liability caps, and increasing insurance requirements.
    • Broad AI definitions can reach beyond their intended scope. Some contracts define AI so broadly that the definition covers nearly any software. When that definition triggers notice, approval, or restrictions on use, it can reach routine work like support and testing. Refining definitions to match the use cases and potential risks is critical to reaching a workable agreement.
    • Confidentiality commitments should match the AI supply chain. Many AI tools, particularly public or free versions, do not protect the confidentiality of the data entered into them, and data used to train a model can be hard to remove. In recent protective order and privilege disputes, courts have required private or enterprise AI environments with enforceable confidentiality terms. In one case, a court found that a provider’s terms allowing it to share data with third parties were enough to defeat a privilege claim. A vendor’s promises to its customers are only as strong as its own agreements with AI companies and subcontractors.

    As health technology becomes more central to care delivery and operations, contract terms increasingly determine how organizations manage regulatory exposure, data rights, and liability. Nixon Peabody’s healthcare, privacy, and intellectual property attorneys advise healthcare organizations and the technology vendors that serve them on these arrangements.

    Practices

    Healthcare TransactionsHealthcareCybersecurity & PrivacyDigital Health & TelemedicineIntellectual PropertyHealth Information - Privacy, Security & Data SharingProduct Liability, Complex Tort & Health EffectsLife Sciences

    Industries

    HealthcareTechnology

    Insights And Happenings

    • Alert

      CMS finalizes 2027 Medicare RPM/RTM changes; direct employee rule delayed to 2029

      Nov 9, 2026
    • Video

      OMIG’s expanded Medicaid audits: What providers need to know

      Nov 3, 2026
    • Article

      Healthtech PE Monitor

      Oct 26, 2026
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Contact Us
    • Privacy Notice
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Supplier Code of Conduct
    • Nixon Peabody International LLP
    • PAL
    © 2026 Nixon Peabody. All rights reserved